RenataCGallagherMDPhD(She/Her)
Medical Genetics • San Francisco, CAClinical Biochemical Genetics, Clinical Genetics
Professor of Clinical Pediatrics, University of California, San Francisco
Dr. Gallagher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th Street
San Francisco, CA 94143Phone+1 415-476-2757Fax+1 415-476-9976
Summary
- Dr. Renata Gallagher is a medical geneticist in San Francisco, CA and is affiliated with UCSF Medical Center. She received her medical degree from UCSF and has been in practice 20 years. She specializes in clinical biochemical genetics and clinical genetics.
Education & Training
University of WashingtonResidency, Pediatrics, 1998 - 2001
University of California San Francisco School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2014 - 2026
CO State Medical License 2006 - 2015
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics- American Board of Medical Genetics and Genomics Clinical Genetics
American Board of Pediatrics Pediatrics
Clinical Trials
- Longitudinal Study of Urea Cycle Disorders Start of enrollment: 2006 Feb 01
- Oxidative Stress, Inflammation and Acute Decompensation in Urea Cycle Disorders Start of enrollment: 2012 Feb 01
- Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Characterization of Factors Associated With Death in Deceased Patients With Mitochondrial Disorders: A Multicenter Cross-Sectional Survey.Alina Ivaniuk, Irina A Anselm, Aaron Bowen, Bruce H Cohen, Fatma Tuba Eminoglu
Neurology. 2025-02-25 - 41-Year-Old Male with Sub-Acute Encephalopathy, Seizures, and End Stage Renal Disease: A Unifying Diagnosis and Response to Therapy.Tameena Wais, Karen P Ibarra, Dattanand M Sudarshana, Meghana Eswarappa, Meyeon Park
The Neurohospitalist. 2024-01-01 - 6 citationsContinued improvement in disease manifestations of acid sphingomyelinase deficiency for adults with up to 2 years of olipudase alfa treatment: open-label extension of ...Melissa P Wasserstein, Robin Lachmann, Carla Hollak, Antonio Barbato, Renata C Gallagher
Orphanet Journal of Rare Diseases. 2023-12-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
